DK1218012T3 - Anvendelse af alprostadil (prostaglandin E1) til fremstilling af et lægemiddel til angioneogenese - Google Patents
Anvendelse af alprostadil (prostaglandin E1) til fremstilling af et lægemiddel til angioneogeneseInfo
- Publication number
- DK1218012T3 DK1218012T3 DK00960220T DK00960220T DK1218012T3 DK 1218012 T3 DK1218012 T3 DK 1218012T3 DK 00960220 T DK00960220 T DK 00960220T DK 00960220 T DK00960220 T DK 00960220T DK 1218012 T3 DK1218012 T3 DK 1218012T3
- Authority
- DK
- Denmark
- Prior art keywords
- angioneogenesis
- alprostadil
- prostaglandin
- drug
- preparation
- Prior art date
Links
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 title abstract 3
- 229960000711 alprostadil Drugs 0.000 title abstract 3
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0163599A AT408314B (de) | 1999-09-24 | 1999-09-24 | Verwendung von alprostadil (prostaglandin e1) zur herstellung eines arzneimittels für angioneogenese |
| PCT/AT2000/000252 WO2001022949A2 (de) | 1999-09-24 | 2000-09-21 | Verwendung von alprostadil (prostaglandin e1) zur herstellung eines arzneimittels für angioneogenese |
| EP00960220A EP1218012B1 (de) | 1999-09-24 | 2000-09-21 | Verwendung von alprostadil (prostaglandin e1) zur herstellung eines arzneimittels für angioneogenese |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1218012T3 true DK1218012T3 (da) | 2005-01-10 |
Family
ID=3517679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00960220T DK1218012T3 (da) | 1999-09-24 | 2000-09-21 | Anvendelse af alprostadil (prostaglandin E1) til fremstilling af et lægemiddel til angioneogenese |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1218012B1 (da) |
| AT (2) | AT408314B (da) |
| AU (1) | AU7260600A (da) |
| DE (1) | DE50007636D1 (da) |
| DK (1) | DK1218012T3 (da) |
| ES (1) | ES2226910T3 (da) |
| WO (1) | WO2001022949A2 (da) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0153858A3 (en) * | 1984-02-29 | 1985-12-11 | The Upjohn Company | The therapeutic use of prostaglandins |
-
1999
- 1999-09-24 AT AT0163599A patent/AT408314B/de not_active IP Right Cessation
-
2000
- 2000-09-21 EP EP00960220A patent/EP1218012B1/de not_active Expired - Lifetime
- 2000-09-21 ES ES00960220T patent/ES2226910T3/es not_active Expired - Lifetime
- 2000-09-21 DK DK00960220T patent/DK1218012T3/da active
- 2000-09-21 AT AT00960220T patent/ATE274909T1/de active
- 2000-09-21 AU AU72606/00A patent/AU7260600A/en not_active Abandoned
- 2000-09-21 WO PCT/AT2000/000252 patent/WO2001022949A2/de not_active Ceased
- 2000-09-21 DE DE50007636T patent/DE50007636D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001022949A3 (de) | 2002-05-02 |
| ES2226910T3 (es) | 2005-04-01 |
| AU7260600A (en) | 2001-04-30 |
| DE50007636D1 (de) | 2004-10-07 |
| EP1218012B1 (de) | 2004-09-01 |
| ATA163599A (de) | 2001-03-15 |
| WO2001022949A2 (de) | 2001-04-05 |
| EP1218012A2 (de) | 2002-07-03 |
| ATE274909T1 (de) | 2004-09-15 |
| AT408314B (de) | 2001-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200300937A1 (ru) | Оральная фармацевтическая композиция цефподоксима проксетила | |
| CR6895A (es) | Nuevos compuestos heterociclicos su preparacion y su utilizacion como medicamentos en especial como antibacterianos | |
| WO2003035005A3 (en) | Heteroindanes: a new class of potent cannabimimetic ligands | |
| HN1999000131A (es) | Derivados del acido hidroxi pipecolato hidroxamico. | |
| DK1162982T3 (da) | Anvendelse af stabiliserede oligonucleotider til fremstilling af et lægemiddel med antitumoral virkning | |
| ES2169147T3 (es) | Derivados de beta-carbolina agonistas de la melatonina, sus procedimientos de preparacion y su utilizacion a titulo de medicamento. | |
| ATE202483T1 (de) | Immuntolerante prothrombinkomplex-präparation | |
| SE9901077D0 (sv) | Novel use | |
| DK1641438T3 (da) | Fremgangsmåde til fremstilling af den amorfe form af et lægemiddel | |
| CY1107635T1 (el) | Μεθοδος για την παρασκευη σιταλοπραμης | |
| NO20014241D0 (no) | C16-umettede FP-selektive prostaglandinanaloger | |
| IT1318667B1 (it) | Medicamento antinfiammatorio. | |
| DK1274414T3 (da) | Nasal administration af Metocloropramid til behandling af Gastroparese | |
| DK1150704T3 (da) | Melagatran til behandling af betændelse | |
| GB2358137B (en) | Compound | |
| SE9904121D0 (sv) | Hydrophobe biomolecular structure | |
| DK1206452T3 (da) | Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser | |
| ATE336891T1 (de) | Pharmazeutisches freigabekonstrukt zur magenretention | |
| HN2001000021A (es) | Nuevos derivados de amidas heterociclicas | |
| DK1267892T3 (da) | Anvendelse af CDP-cholin til behandling af alkoholabstinenssyndrom | |
| AU7260600A (en) | Use of alprostadil (prostaglandin e1) for producing a medicament for angioneogenesis | |
| ATE249204T1 (de) | Spray, enthaltend ubichinon qn | |
| DK1399143T3 (da) | Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni | |
| NO20014889D0 (no) | Fremgangsmåte for fremstilling av medisinske midler | |
| DK1399141T3 (da) | Anvendelse af acetyl L-carnitin til fremstilling af et lægemiddel til forebyggende terapi af post-kirurgisk smerte |